Bioprocessing - Upstream & Downstream

Step into the design space and your life will be changed forever.

Tony Hitchcock discusses his career and the evolution of the gene therapy market.

Gene is excited about the hot new trend in process development...

Higher productivity, lower hold times, lower costs… continuous processing for monoclonal antibodies could offer a number of advantages.

There could be significant benefits to implementing additional measures in upstream bioprocesses to prevent viral contamination.

Gene's ingenuity catches Eva off guard, but is all as it seems?

The Jefferson Institute for Bioprocessing is up and running after just two years. How did they do it? And what courses are on offer?

Cell therapy manufacturing? It's time to scale out.

Digitalization means a more productive and adaptive plant through the application of analytics to leverage connectivity and data.

Do you want to share the story behind your technology in a future issue of The Medicine Maker?